Allopurinol in primary gout with and after the administration of uricosuric agents.
D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D057487:Enzyme Therapy; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood; D014969:Xanthine Oxidase
D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase; D013442:Sulfinpyrazone